Journal for ImmunoTherapy of Cancer (Nov 2023)
134 mNTX-250, a novel multimodal HPV-16 mRNA-based therapeutic, induces potent anti-tumor responses and establishes HPV-16 specific immune memory
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)